| 摘要 |
A new stable solid composition suitable for oral administration comprising a pharmaceutically acceptable acid addition salt of selegiline is achieved by reducing the destabilising effect of the conventional lubricant present in such compositions, magnesium stearate, by adding to the selegiline-containing tablets, a pharmaceutically acceptable acid having a pKa value below 5.88. |
